Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- UCB Aims at Innovation for Specialists
December 12, 2005
- SELF-MEDICATION NEWS IN BRIEF
December 12, 2005
- Discussions on OTC Drug Marketing to Conclude Soon
December 12, 2005
- Japan Lags Behind in Use of Insulin Pump for Type 1 Diabetics
December 12, 2005
- Breast Cancer Screening Needed in Women in Their 40s: Prof. Ohuchi
December 12, 2005
- SURVEY 2 articles
December 12, 2005
- Saitama Medical School Creates Wound Healing & Regenerative Medicine Center
December 12, 2005
- Dr Takenaka Talks on Pharma Industry 10 Years Back and 10 Ahead
December 12, 2005
- MEDICAL DEVICE NEWS IN BRIE
December 12, 2005
- 23 TSE-listed Drug Firms' Sales Up 2.7% to \2,764,792 Mil.
December 12, 2005
- R&D NEWS IN BRIEF
December 12, 2005
- REGULATORY NEWS IN BRIEF
December 12, 2005
- Supply of All Specifications "Hurdle That Must Be Overcome": JGPMA
December 12, 2005
- HEALTHCARE FORUM
December 12, 2005
- BUSINESS NEWS IN BRIEF
December 12, 2005
- Councilor Calls For Medical, Nursing Fees that Promote Home Care
December 12, 2005
- Korosho Proposes Simplification of Dispensing Fees
December 12, 2005
- 4 Industry Groups Present Their Views at Chuikyo
December 12, 2005
- Chuikyo Makes No Recommendation on Medical Fee Revision
December 12, 2005
- Decision on Pricing of Long-listed Products in Limbo Until Year-end
December 12, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…